Search results
Mankind Pharma inks pact with Takeda to commercialise acidity drug in India
Business Standard India· 20 hours agoThe agreement allows Mankind Pharma to launch the novel drug for treating Gastroesophageal Reflux...
Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India - ET HealthWorld | Pharma
The Economic Times· 21 hours agoThe pharma company has signed a Non-Exclusive Patent License Agreement with Takeda Pharmaceuticals...
Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in India
Financial Express· 24 hours agoVonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related...
USFDA approves Glenmark’s generic formulation to treat epilepsy
Financial Express· 35 minutes agoGlenmark Pharmaceuticals Ltd. on Wednesday announced that it has received final approval from the...
Ipca, Glenmark, Sun, Zydus, Mankind, Ajanta, power Pharma market growth in June, that softened over...
Livemint· 2 days agoStock Market Today: Indian Pharma market growth at 6.7% yoy in June softened over April and May....
Pharma sector likely to report 8-10% revenue growth led by domestic business - CNBC TV18
CNBC TV18· 19 hours agoPharmaceutical companies are expected to kick off FY25 with around 8-10% growth in revenue led by...
Block deals: Canada Pension Plan sells 0.5% in Nykaa for Rs 256 cr; Hema CIPEF offloads 0.46% in ...
The Economic Times· 7 days agoThrough the stake sale, Canada Pension Plan took home about Rs 256 crore. At the end of March...
₹771 Crore Block Deal Shakes Up Mankind Pharma Stock | India Infoline
India Infoline· 7 days agoOn July 10, about 37 lakh shares, or 0.9% of Mankind Pharma’s equity, were sold in block agreements for a total of ₹771 core. The participants to the sale ...
Pharma and healthcare sector seals $4.1 bn deals in Q2 2024: Report
Business Standard India· 20 hours agoHealthcare funding India Q2: The average deal size also saw a jump, rising from $9.7 million in Q1...
Stock market update: Nifty Pharma index advances 0.09% in an upbeat market
The Economic Times· 1 day agoThe Nifty Pharma index was trading 0.09 per cent up at 20862.7.